D/C/F/TAF achieved high virologic response rates that were overall noninferior to the control D/C+F/TDF, as well as favorable bone and renal outcomes that were consistent across age, gender, and race subgroups in phase 3 AMBER trial.
News
Advertisement
An Australian study found patients were better informed and more empowered when they signed up for a national registry of spleen disease patients.
Advertisement
Maintaining consistent environmental cleaning and disinfection is critical to warding off emerging and re-emerging pathogens.
Taking into account the severity of this flu season, it is important that health care providers understand and choose the best treatment option for each patient.
In case you missed them, we've compiled a list of the latest US Food and Drug Administration (FDA) recalls posted this week.
In the wake of news of 10 travelers being infected with yellow fever, 4 of whom have died, the Centers for Disease Control and Prevention (CDC) are urging anyone considering travel to yellow fever endemic regions of Brazil to be vaccinated prior to travel.
Advertisement
Posthoc analysis of the EMERALD trial reveal the combination regimen of D/C/F/TAF performs well in HIV-positive patients across different race, gender, and age subgroups, who may have failed previous antiviral regimens.
In case you missed them, we've compiled the top five infectious disease articles from this past week.
All doses of MK-8591 were generally well-tolerated with a limited number of reported mild/moderate adverse events.
Recent research presented at CROI 2018 finds that the risk of female HIV acquisition per sex act steadily increased through pregnancy and was highest during postpartum.
Advertisement
Recent research presented at CROI reveals that doxycycline is an acceptable treatment alternative for HIV-positive patients who are infected with syphilis.
The Global Virome Project is set to launch in 2018, and will spend the next 10 years working to identify as many as 827,000 unknown viruses in the wild.
The New Jersey Department of Health has issued a public health alert warning of another potential measles exposure at Newark International Airport.
Researchers discuss a new method to rapidly detect HIV time-space clusters for public health intervention at CROI 2018.
At present, multiple vaccine candidates are in various stages of research and development, including cabotegravir, which is currently in phase 3 trials, and vaccines based on broadly-neutralizing antibodies.
As flu activity continues to decline in the United States, some states are still reporting a record number of flu illnesses, as a new study debunks concerns that the use of Tamiflu may lead to increased suicide risk in teens.
Scientists from the NIH and Rutgers New Jersey Medical School are in the process of developing a promising alternative to antibiotic treatments for multidrug-resistant Klebsiella pneumoniae bacteria.
A recent study has found that patients with HIV are six times more likely to have schizophrenia compared with those who do not have the virus.
Essential oils are popular, but they could be a source of disease spread in health care settings.
Hair levels are found to be the strongest independent predictor of virologic success in a recent treatment trial.
At CROI 2018, Dr. Patricia Flynn discussed the impact of ART on individuals with perinatal HIV infections, and how far the infectious disease community has come since its initial use.
Raltegravir-intensified therapy resulted in significantly faster viral load declines in HIV-infected adults and older children but did not reduce overall mortality or WHO 3/4 events compared with standard triple-drug ART.
In the wake of Europe’s recent 4-fold increase in measles cases, countries such as Italy, Germany, and Romania are passing tougher laws requiring vaccinations for children being enrolled in school.
A recent study finds that outbreaks of Valley fever have a wider geographic distribution than previously thought.
Mental health is a critical component of ending the HIV epidemic.
In case you missed them, we’ve compiled a list of the latest recalls posted this week.
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
At CROI 2018, Dr. Linda-Gail Bekker highlighted 7 controversies surrounding PrEP and provided conference attendees with enough evidence to separate fact from fiction.
The medical community has learned many lessons by looking back on the early days of the HIV/AIDS epidemic, including the value of multidisciplinary teams, the vital role of acute care clinicians, and more.
The Antibacterial Resistance Leadership Group (ARLG) is working to enroll patients in clinical trials of 2 investigational monoclonal antibodies, with the ultimate goal of reducing antimicrobial resistance.
